Treating Patients With Essential Thrombocytopenia

Treating Patients With Essential Thrombocytopenia

Essential Thrombocythemia: What Patients Should Know (2022) | Top MPN Specialist Dr. Ruben Mesa

The Patient Story

What Are Treatment Options for Essential Thrombocythemia?

Patient Empowerment Network

Advances in the risk stratification and treatment of essential thrombocythemia

VJHemOnc – Video Journal of Hematology & HemOnc

Emerging Therapies in Essential Thrombocytopenia

Essential Thrombocythemia

Update on CLL/SLL for Newly Diagnosed Patients | Lymphoma Research Foundation Webinars

Lymphoma Research Foundation

Andrea's ET Story: Understanding Her Diagnosis

Challenges in the treatment and management of ET and the need to improve therapeutic approaches

VJHemOnc – Video Journal of Hematology & HemOnc

Essential Thrombocythemia Watch & Wait | What Patients Should Know

Patient Empowerment Network

The unmet needs of essential thrombocythemia and polycythemia vera patients

VJHemOnc – Video Journal of Hematology & HemOnc

QoL for patients with polycythemia vera or essential thrombocythemia

VJHemOnc – Video Journal of Hematology & HemOnc

What is Essential Thrombocythemia (ET)?

Silver MPN Center

Treatment goals in Essential Thrombocythemia and Polycythemia vera

Advances in Essential Thrombocythemia Research

Patient Empowerment Network

PT-1 study update: addition of hydroxyurea to aspirin in essential thrombocythemia

VJHemOnc – Video Journal of Hematology & HemOnc

SURPASS ET: ropeginterferon versus anagrelide as second line therapy in essential thrombocythemia

VJHemOnc – Video Journal of Hematology & HemOnc

What is Thrombocytosis? Diagnosis & Treatment of High Platelets | Rapid Review

Essential Thrombocytosis (ET) | Myeloproliferative Neoplasm (JAK2 Kinase)

Medicosis Perfectionalis

Managing Essential Thrombocythemia in 2021 - Dr. Tiziano Barbui

MPN Education Foundation